[1]
“Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data”, Swiss Med Wkly, vol. 153, no. 9, p. s3441 , Sep. 2023, doi: 10.57187/s.3441.